Glenmark plans capexIllustrative image – not actual.

Pharma major, Glenmark is planning to raise around USD 200 million, of which International Finance Corporation (IFC) is planning to invest upto USD 75 million. The company plans to raise the money through market issuance of quasi-equity instruments.

The proposed investment of upto USD 75 million will be used for expanding its manufacturing capacity (primarily in India); building research and development (R&D) capacity for new products (including in India); and reducing debt so that internal accruals can be deployed to R&D.

The proposed fund raising of USD 200 million is to support the company’s expansion of domestic manufacturing and for a ‘significant’ amount in capital expenditure over the next three years across its facilities in India.

← All latest storiesBack to top →